Hem › Non-Hodgkins lymfom › North Carolina
Kliniska studier för Non-Hodgkins lymfom i North Carolina
24 studier för Non-Hodgkins lymfom söker deltagare vid platser i North Carolina.
Städer i North Carolina
Officiell studietext (engelska)
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
- GC2202 Study Site 109, Greenville
- GC2202 Decentralized Study Site 114, Morrisville
- GC2202 Study Site 117, Wilson
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 30 sep. 2026 · NCT05645107TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Lineberger Comprehensive Cancer Center, Chapel Hill
- Atrium Health's Levine Cancer Institute, Charlotte
RekryterarFas 2
Ålder 12 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT02693535Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
- Research Site, Charlotte
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 11 sep. 2026 · NCT06526793Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- Atrium Health Wake Forest Baptist, Winston-Salem
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 25 aug. 2026 · NCT05826535Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
- University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill
RekryterarFas 1/2
Ålder 13 till 90 · Alla kön · Uppdaterad 6 aug. 2026 · NCT06533579Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
- Duke University Medical Center - Division of Hematologic Malignancies, Durham
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 5 aug. 2026 · NCT06116110A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
- Duke Cancer Institute, Durham
- Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 4 aug. 2026 · NCT07188558DALY II USA/ MB-CART2019.1 for DLBCL
- Duke University Medical Center - Division of Hematologic Malignancies, Durham
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 13 juli 2026 · NCT04792489Pre-malignant States to Hematologic Malignancies in Firefighters
- Levine Cancer Institute, Charlotte
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 40 till 49 · Alla kön · Uppdaterad 13 juli 2026 · NCT06870760A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- University of North Carolina at Chapel Hill, Chapel Hill
- Levine Children's Hospital, Charlotte
- Duke University Medical Center, Durham
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 6 juli 2026 · NCT01351545Registry of Older Patients With Cancer
- Seby B. Jones Cancer Center, Boone
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill
- East Carolina University, Greenville
- och 4 fler
RekryterarObservationsstudie
Ålder 65 och äldre · Alla kön · Uppdaterad 29 juni 2026 · NCT01137825Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
- University of North Carolina, Chapel Hill
RekryterarFas 1
Ålder 13 och äldre · Alla kön · Uppdaterad 5 maj 2026 · NCT04771572CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- Duke University Medical Center, Duke Cancer Center, Durham
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 16 apr. 2026 · NCT03328078The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
- Wake Forest Baptist Health, Winston-Salem
RekryterarObservationsstudie
Ålder 18 till 120 · Alla kön · Uppdaterad 13 apr. 2026 · NCT01890486Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Atrium Health Stanly/LCI-Albemarle, Albemarle
- Cone Health MedCenter Asheboro, Asheboro
- Cone Health Cancer Center at Alamance Regional, Burlington
- och 21 fler
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 17 mars 2026 · NCT06418204A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
- Duke University Medical Center, Durham
RekryterarFas 4
Ålder 18 och äldre · Alla kön · Uppdaterad 2 mars 2026 · NCT06876649A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
- Duke University Medical Center, Durham
RekryterarFas 4
Ålder 18 och äldre · Alla kön · Uppdaterad 2 mars 2026 · NCT06876662Study of SGR-1505 in Mature B-Cell Neoplasms
- Duke University, Durham
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 13 feb. 2026 · NCT05544019A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors
- Carolina BioOncology, Huntersville
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 4 feb. 2026 · NCT05892718AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
- Duke University, Durham
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 10 dec. 2025 · NCT05602363SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Chapel Hill
- Massive Bio SYNERGY-AI site, Winston-Salem
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 28 okt. 2025 · NCT03452774Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill
RekryterarObservationsstudie
Ålder 18 till 120 · Alla kön · Uppdaterad 27 okt. 2025 · NCT01137643A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
- University of North Carolina, Chapel Hill
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 2 okt. 2025 · NCT05780034IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
- Atrium Health Wake Forest Baptist, Winston-Salem
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 3 juni 2025 · NCT06119685Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.